HUP0300020A2 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- HUP0300020A2 HUP0300020A2 HU0300020A HUP0300020A HUP0300020A2 HU P0300020 A2 HUP0300020 A2 HU P0300020A2 HU 0300020 A HU0300020 A HU 0300020A HU P0300020 A HUP0300020 A HU P0300020A HU P0300020 A2 HUP0300020 A2 HU P0300020A2
- Authority
- HU
- Hungary
- Prior art keywords
- novel compounds
- group
- compounds
- triazolyl
- furyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- -1 nitro- Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
A találmány tárgyát az általános képletű vegyületek - ahol R1 adottesetben egymástól függetlenül l, 2 vagy 3 alkil-, nitro-,. trifluor-metil-, alkoxicsoporttal, halogénatommal szubsztituált fenil-,piridil-, tienil-, furil-, imidazolil- vagy triazolilcsoport - ésgyógyszerészetileg elfogadható sóik és izomereik és alkalmazásukképezik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904674A SE9904674D0 (sv) | 1999-12-20 | 1999-12-20 | Novel compounds |
PCT/SE2000/002562 WO2001046174A1 (en) | 1999-12-20 | 2000-12-15 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300020A2 true HUP0300020A2 (en) | 2003-05-28 |
HUP0300020A3 HUP0300020A3 (en) | 2005-02-28 |
Family
ID=20418210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300020A HUP0300020A3 (en) | 1999-12-20 | 2000-12-15 | Novel compounds |
Country Status (31)
Country | Link |
---|---|
US (2) | US6680318B2 (hu) |
EP (1) | EP1242410B1 (hu) |
JP (1) | JP2003522741A (hu) |
KR (2) | KR100769814B1 (hu) |
CN (1) | CN1608064A (hu) |
AT (1) | ATE275143T1 (hu) |
AU (1) | AU780799B2 (hu) |
BG (1) | BG65457B1 (hu) |
BR (1) | BR0016591A (hu) |
CA (1) | CA2395300A1 (hu) |
CZ (1) | CZ20022124A3 (hu) |
DE (1) | DE60013486T2 (hu) |
DK (1) | DK1242410T3 (hu) |
EE (1) | EE200200337A (hu) |
ES (1) | ES2225289T3 (hu) |
HK (1) | HK1048308B (hu) |
HU (1) | HUP0300020A3 (hu) |
IL (2) | IL150125A0 (hu) |
IS (1) | IS2143B (hu) |
MX (1) | MXPA02006063A (hu) |
NO (1) | NO322432B1 (hu) |
NZ (1) | NZ519986A (hu) |
PL (1) | PL356780A1 (hu) |
PT (1) | PT1242410E (hu) |
RU (1) | RU2258703C2 (hu) |
SE (1) | SE9904674D0 (hu) |
SI (1) | SI1242410T1 (hu) |
SK (1) | SK8832002A3 (hu) |
UA (1) | UA71650C2 (hu) |
WO (1) | WO2001046174A1 (hu) |
ZA (1) | ZA200204255B (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040067950A1 (en) * | 1998-07-27 | 2004-04-08 | Schering-Plough Corporation | High affinity ligands for nociceptin receptor ORL-1 |
SE9904674D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
WO2002094794A1 (en) * | 2001-05-18 | 2002-11-28 | Astrazeneca Ab | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
EP1450807B1 (en) * | 2001-10-29 | 2013-12-25 | Versi Group, LLC | Method of treating depression with delta receptor agonist compounds |
SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0203302D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0301441D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
EP1697307B1 (en) | 2003-12-12 | 2014-03-12 | Eli Lilly & Company | Opioid receptor antagonists |
SE0400027D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
KR101234421B1 (ko) | 2004-08-02 | 2013-02-18 | 아스트라제네카 아베 | 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도 |
CN101128447A (zh) * | 2005-02-28 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 二芳基甲基哌嗪衍生物,其制备及其用途 |
GB0606876D0 (en) * | 2006-04-05 | 2006-05-17 | Glaxo Group Ltd | Compounds |
BRPI0912756A2 (pt) * | 2008-05-20 | 2015-10-13 | Astrazeneca Ab | método para tratar transtorno depressivo maior ansioso em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH585209A5 (hu) | 1973-06-29 | 1977-02-28 | Cermol Sa | |
DE2900810A1 (de) | 1979-01-11 | 1980-07-24 | Cassella Ag | Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung |
IT1140978B (it) | 1980-05-23 | 1986-10-10 | Selvi & C Spa | 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche |
GB8320701D0 (en) | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agent |
IT1196150B (it) | 1984-06-19 | 1988-11-10 | Poli Ind Chimica Spa | Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono |
SE8500573D0 (sv) | 1985-02-08 | 1985-02-08 | Ferrosan Ab | Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain |
US5028610A (en) | 1987-03-18 | 1991-07-02 | Sankyo Company Limited | N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use |
US4829065A (en) | 1987-04-24 | 1989-05-09 | Syntex Pharmaceuticals, Ltd. | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
US4826844A (en) | 1987-09-30 | 1989-05-02 | American Home Products Corporation | Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols |
ATE102831T1 (de) | 1989-11-22 | 1994-04-15 | Janssen Pharmaceutica Nv | Verfahren zur verhuetung oder zur begrenzung einer reperfusionsschaedigung. |
US5807858A (en) | 1996-06-05 | 1998-09-15 | Delta Pharmaceutical, Inc. | Compositions and methods for reducing respiratory depression |
GB9202238D0 (en) | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
US5681830A (en) | 1992-02-03 | 1997-10-28 | Delta Pharmaceuticals, Inc. | Opioid compounds |
US5574159A (en) | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
FR2696744B1 (fr) | 1992-10-12 | 1994-12-30 | Logeais Labor Jacques | Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique. |
CA2168432C (en) | 1993-07-30 | 2004-03-23 | Kwen-Jen Chang | Piperazine compounds used in therapy |
JP3352184B2 (ja) | 1993-11-12 | 2002-12-03 | 株式会社アズウェル | ピペラジン不飽和脂肪酸誘導体 |
US5693843A (en) * | 1995-12-22 | 1997-12-02 | E. I. Du Pont De Nemours And Company | Process for hydrocyanation of diolefins and isomerization of nonconjugated 2 alkyl-3-monoalkenenitriles |
SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
SE9604786D0 (sv) | 1996-12-20 | 1996-12-20 | Astra Pharma Inc | New compounds |
TW548271B (en) | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
JP4754068B2 (ja) | 1997-12-24 | 2011-08-24 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | δ−オピオイドレセプターに結合する4−[アリール(ピペリジン−4−イル)]アミノベンズアミド類 |
SE9904674D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
-
1999
- 1999-12-20 SE SE9904674A patent/SE9904674D0/xx unknown
-
2000
- 2000-12-15 US US10/149,981 patent/US6680318B2/en not_active Expired - Fee Related
- 2000-12-15 EE EEP200200337A patent/EE200200337A/xx unknown
- 2000-12-15 MX MXPA02006063A patent/MXPA02006063A/es active IP Right Grant
- 2000-12-15 CA CA002395300A patent/CA2395300A1/en not_active Abandoned
- 2000-12-15 JP JP2001547084A patent/JP2003522741A/ja not_active Abandoned
- 2000-12-15 AT AT00987916T patent/ATE275143T1/de not_active IP Right Cessation
- 2000-12-15 PL PL00356780A patent/PL356780A1/xx not_active IP Right Cessation
- 2000-12-15 IL IL15012500A patent/IL150125A0/xx active IP Right Grant
- 2000-12-15 UA UA2002064617A patent/UA71650C2/uk unknown
- 2000-12-15 DK DK00987916T patent/DK1242410T3/da active
- 2000-12-15 CZ CZ20022124A patent/CZ20022124A3/cs unknown
- 2000-12-15 WO PCT/SE2000/002562 patent/WO2001046174A1/en active IP Right Grant
- 2000-12-15 ES ES00987916T patent/ES2225289T3/es not_active Expired - Lifetime
- 2000-12-15 HU HU0300020A patent/HUP0300020A3/hu unknown
- 2000-12-15 NZ NZ519986A patent/NZ519986A/en unknown
- 2000-12-15 SI SI200030501T patent/SI1242410T1/xx unknown
- 2000-12-15 PT PT00987916T patent/PT1242410E/pt unknown
- 2000-12-15 AU AU24184/01A patent/AU780799B2/en not_active Ceased
- 2000-12-15 EP EP00987916A patent/EP1242410B1/en not_active Expired - Lifetime
- 2000-12-15 KR KR1020027007836A patent/KR100769814B1/ko not_active IP Right Cessation
- 2000-12-15 CN CNA008190461A patent/CN1608064A/zh active Pending
- 2000-12-15 DE DE60013486T patent/DE60013486T2/de not_active Expired - Fee Related
- 2000-12-15 KR KR1020077019022A patent/KR20070090050A/ko not_active Application Discontinuation
- 2000-12-15 BR BR0016591-3A patent/BR0016591A/pt not_active Application Discontinuation
- 2000-12-15 SK SK883-2002A patent/SK8832002A3/sk unknown
- 2000-12-15 RU RU2002114343/04A patent/RU2258703C2/ru not_active IP Right Cessation
-
2002
- 2002-05-28 ZA ZA200204255A patent/ZA200204255B/en unknown
- 2002-06-10 IL IL150125A patent/IL150125A/en not_active IP Right Cessation
- 2002-06-10 BG BG106805A patent/BG65457B1/bg unknown
- 2002-06-18 NO NO20022920A patent/NO322432B1/no unknown
- 2002-06-18 IS IS6426A patent/IS2143B/is unknown
-
2003
- 2003-01-08 HK HK03100216.5A patent/HK1048308B/zh not_active IP Right Cessation
- 2003-11-17 US US10/714,448 patent/US20040138225A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300020A2 (en) | Novel compounds | |
DE602005023185D1 (de) | Prodrugs mit neuen biospaltbaren verbindern | |
ATE267175T1 (de) | Pyrimidin derivate | |
TR199902400T2 (xx) | Fungusit etkinlik g�steren terkiplerin birle�imleri. | |
HUP0104483A2 (hu) | Fungicid hatóanyagkombinációk és alkalmazásuk | |
CY1113813T1 (el) | Νεες ενωσεις που εχουν ανασταλτικη δραστικοτητα εναντια στον εξαρτωμενο απο το νατριο μεταφορεα | |
DE69817802D1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
DE69925133D1 (de) | Pyrrolobenzodiazepine | |
ATE302775T1 (de) | Carbolinderivate | |
CY1105836T1 (el) | 12, 13-τροποποιημενα παραγωγα εποθιλονης | |
EA200100826A1 (ru) | 16-галогенопроизводные эпотилона, способ их получения и их применение в фармацевтике | |
ATE303987T1 (de) | Phenoxypropylamin-derivate | |
DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
AU2002346271A1 (en) | Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use | |
UY27338A1 (es) | Nuevos derivados de ácido sulfónico | |
BR0115501A (pt) | Processo quìmico e novos intermediários | |
HUP0202881A2 (hu) | Antisztatikum | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
DE50101861D1 (de) | Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung | |
DE69810960D1 (de) | 2-phenoxyanilin-derivate | |
HUP0401949A2 (hu) | 4-Imidazolin-2-on-származékok | |
ATE259813T1 (de) | Triazolopyrimidinderivate | |
PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
ES2185459B1 (es) | Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo. | |
MY102440A (en) | Fungicidal pyridyl cyclopropane carboxamides. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |